- Home
- IDN vs XBIT Comparison
IDN vs XBIT Comparison
Compare IDN & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDN
- XBIT
- Stock Information
- Founded
- IDN 1994
- XBIT 2005
- Country
- IDN United States
- XBIT United States
- Employees
- IDN N/A
- XBIT N/A
- Industry
- IDN Computer Software: Prepackaged Software
- XBIT Pharmaceuticals and Biotechnology
- Sector
- IDN Technology
- XBIT Health Care
- Exchange
- IDN Nasdaq
- XBIT Nasdaq
- Market Cap
- IDN 101.6M
- XBIT 82.3M
- IPO Year
- IDN 1999
- XBIT 2015
- Fundamental
- Price
- IDN $4.58
- XBIT $2.67
- Analyst Decision
- IDN Strong Buy
- XBIT
- Analyst Count
- IDN 3
- XBIT 0
- Target Price
- IDN $6.17
- XBIT N/A
- AVG Volume (30 Days)
- IDN 97.1K
- XBIT 175.4K
- Earning Date
- IDN 11-12-2025
- XBIT 11-10-2025
- Dividend Yield
- IDN N/A
- XBIT N/A
- EPS Growth
- IDN N/A
- XBIT N/A
- EPS
- IDN N/A
- XBIT N/A
- Revenue
- IDN $20,662,000.00
- XBIT N/A
- Revenue This Year
- IDN $9.73
- XBIT N/A
- Revenue Next Year
- IDN $11.75
- XBIT N/A
- P/E Ratio
- IDN N/A
- XBIT N/A
- Revenue Growth
- IDN 7.12
- XBIT N/A
- 52 Week Low
- IDN $2.17
- XBIT $2.09
- 52 Week High
- IDN $6.49
- XBIT $7.74
- Technical
- Relative Strength Index (RSI)
- IDN 42.27
- XBIT 57.77
- Support Level
- IDN $4.36
- XBIT $2.09
- Resistance Level
- IDN $4.60
- XBIT $3.44
- Average True Range (ATR)
- IDN 0.21
- XBIT 0.20
- MACD
- IDN 0.01
- XBIT 0.06
- Stochastic Oscillator
- IDN 51.19
- XBIT 48.15
About IDN Intellicheck Inc.
Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.